Objective. To determine factors affecting morbidity and mortality in a contemporary cohort of hospitalized SLE patients and estimate the rate of SLE hospitalization. Results. There were a total of 96 SLE patients meeting inclusion criteria hospitalized during this period resulting in 154 hospitalizations. Average age at diagnosis was 33.3 years (S.D. 13.7) and 46.5 years (S.D. 14.1) at hospitalization; 91.7% of hospitalized patients were female. The most common reasons for hospitalization included disease flare (17.5%), infection (mostly bacterial) (16.2%) and adverse drug reaction (8.1%). Acute coronary syndrome (2.6%) and venous thromboembolic events (1.9%) were less common causes of hospitalization. Mean hospitalization length was 8.5 (S.D. 11.2) days. Intensive care unit (ICU) admission occurred in 22 cases (13.8%) and mortality was significantly higher (27.3% of ICU patients died; P < 0.001). ICU admissions were associated with longer hospitalization [18.6 (S.D. 17.8) days; P = 0.006]. The annual rate of hospitalizations for SLE was estimated as between 8.6% and 18.9% per year depending on the estimated size of the referral area and study year.
Introduction
SLE is a chronic autoimmune illness with a remitting and relapsing course and variable presentation [1] . It can affect multiple organ systems and holds the potential of having severe consequences in several organ systems [1] .
With increased understanding of the disease process, survival of patients with SLE has improved over recent decades [2, 3] ; however, disease morbidity still remains a significant issue. It has previously been estimated that the mean annual direct health care cost per SLE patient in Canada is roughly $6000 (1990 Canadian dollars) [4] , with approximately a quarter to a half of direct health care costs being directly attributed to acute hospitalization [4] .
Several publications have studied causes and predictors of hospitalization in patients with SLE [5] . These studies have shown similar causes of hospitalization, but the frequency of hospitalization for the different admissions has varied significantly, with hospitalizations for SLE flare ranging from 11% to 80.8% [58] and infectious causes of hospitalization ranging from 10.9% to 37% [58] . It may be important to study hospitalizations in a contemporary cohort of North American SLE patients in order to assess whether the reasons for hospitalization are changing and to help determine the economic burden of SLE. In an attempt to answer these questions, we studied all patients admitted to all hospitals in London, Ontario, Canada, over 3.5 years. Patients were identified by the discharge diagnosis code M32, which refers to SLE as per the International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD V10). Exclusion criteria were age <18 years at the time of hospitalization, data on hospitalization were unavailable in the chart and patients not meeting the ACR SLE classification criteria.
Methods
Patient demographics, disease history and medication lists were obtained from hospitalization and clinic visit notes in the electronic patient record. Co-morbid conditions were quantified with the Charlson Co-Morbidity Data questionnaire score [9] . The primary cause for hospitalization was determined by a physician (J.L.) based on review of hospitalization records. In-hospital morbidity was determined by the length of hospitalization, number of consulting services involved and intensive care unit (ICU) requirement.
Descriptive statistics were obtained using standard statistical methods, with means (S.D.) used for continuous variables and percentages used for other variables. Statistical analyses were done using SPSS version 20 (IBM, Armonk, NY, USA). Independent-samples t-test analysis was performed to identify differences in demographics and co-morbidity scores. Chi-square analyses assessed differences in medication use, laboratory results and access to a rheumatologist/family physician. Descriptive analyses were based on first hospital admission; other statistics were calculated using all hospital admissions during the study period (such as the rate of hospitalization each year under study). Reasons for hospitalizations were compared with other SLE publications, determined by performing a computer-assisted search of the English literature for SLE/lupus and hospitalization.
The annual rate of hospitalizations for SLE patients was estimated using some known statistics. London Health Sciences Centre and St Joseph's Hospital in London, Ontario, comprise a large academic teaching centre at the Western University and are the only hospitals for acute care in the city. They are secondary and tertiary referral sites for surrounding hospitals. London has a large catchment area for outpatient referrals. In 2006 the city of London had a population of 457 720 [10] . The referral population is estimated at 1 million [11], although not all SLE hospitalizations for the region would have occurred in the teaching hospitals. The prevalence of SLE in Canada is approximately 51 in 100 000 [12] , so the number of patients with SLE in London is approximately 233, but in the catchment it could be as high as 510.
Results
There were a total of 147 patients hospitalized with a discharge diagnosis ICD V10 code M32 from January 2006 to June 2009. Ninety-six of these patients met study inclusion criteria for a combined total of 154 hospitalization events. Average age at diagnosis was 33.3 (13.7) years and 46.5 (14.1) years at hospitalization, with the majority of hospitalized patients being female (91.7%). Data were insufficient to determine patient ethnic background or level of education.
The most common overall reason for hospitalization was disease flare (17.5%), where renal and haematological Renal (10) Haematological (10) Serositis (8) Neurological (6) Mucocutaneous (3) Pulmonary haemorrhage (1) Infection
Types of infection (n)
Vasculitic ulcer infection (1 flares were the most frequent manifestations (Table 1) . Infection (particularly bacterial) (16.2%) and adverse drug reaction (8.1%) were the next most common causes (Table 1) . Pregnancy complications and labour accounted for 9% of admissions. Acute coronary syndrome (2.6%) and venous thromboembolic event (1.9%) were uncommon causes for hospitalization (Table 1) . Of the 154 hospitalization events, 60 (39.0%) could be attributed to either an SLE flare or a complication related to SLE. Patients hospitalized for SLE disease flare compared with other causes had a shorter disease duration [9.6 (8.2) years; P = 0.032], had seen their rheumatologist more recently [1.4 (1.1) months; P = 0.016] and were on higher doses of prednisone on admission [27.8 (18.6) mg; P = 0.003]. These patients also required a greater number of consulting services (P = 0.011). There were no significant differences in age, ICU requirement or rate of death between these two groups.
The average length of hospitalization for all patients was 8.5 (11.2) days. There was no significant difference in length of stay between patients admitted with SLE flare [11.8 (12.7) days] and those admitted for non-SLE flare reasons [7.7 (10.7) days].
A total of 22 of the 154 hospitalization events (14.3%) resulted in ICU care ( Table 2 ). The length of stay [18.6 (17.8) days; P = 0.006] and death rate (P < 0.001) were higher in patients requiring ICU care than those who did not. There were no significant differences in age, gender, SLE disease duration, pre-admission Charlson comorbidity score or admission SLE medications in those requiring ICU stay compared with those who did not.
Of the 154 hospitalizations, 9 (5.8%) resulted in death. Of those who died, two were initially hospitalized for SLE disease flare, and the majority required ICU stay (66.7%) ( Table 2 ). There were no significant differences between those who died in hospital vs those who survived with respect to age, duration of disease, Charlson co-morbidity score or admission medications.
Between January 2006 and mid-2009 there were 154 confirmed adult SLE hospitalizations. Thus the annual rate of hospitalizations for SLE was between 8.6% and 18.9% per year, where the higher rate is an overestimate, as it does not account for out-of-city catchment and the low rate does not detect all regional hospitalizations and underascertains the true annual hospitalizations in SLE.
Discussion
The most common reasons for hospitalization in SLE patients in our study were disease flare and infection, which is consistent with other studies [58] . The overall percentage of admissions for these causes was comparable to other North American data, with SLE flares accounting for 17.5% of admissions (compared with 11.7% and 35% noted in the Thorburn and Ward [6] and Petri and Genovese [5] studies, respectively) and infection representing 16.2% of admissions (compared with 10.9% and 14% in other studies [6, 5] ). Hospitalization frequencies for SLE flare and infection appeared to be lower, however, compared with Asian populations, which found 5880.8% of admissions for SLE flare and 23.237% of admissions for infection [7, 8] . These lower North American frequencies may be due to underlying ethnic and socio-economic differences, different criteria for hospitalization, better infection prevention strategies or more aggressive and successful treatment of these conditions in the outpatient setting in North America, leading to fewer severe SLE flares requiring hospitalization. Aggressive treatment strategies may be a contributing factor to admissions for adverse drug events (8.1%), which has been shown to lengthen hospitalization stay among rheumatic patients [13] .
Patients admitted for SLE flare had a shorter disease duration, had seen their rheumatologist more recently and were on a higher dose of prednisone than those admitted for other reasons. Zhu et al. [14] found that patients admitted for disease flare had shorter disease duration and higher disease activity at the time of admission. Data suggest that disease activity is higher in the initial 5 years after diagnosis [3] .
Coronary artery disease (CAD) and venous thromboembolic events were less common causes of hospitalization, which is consistent with other studies [57] . Deep venous thrombosis and minor pulmonary embolisms are often treated in outpatient anticoagulation clinics, negating the need for inpatient admissions. While patients with SLE are at a higher risk of CAD compared with the general population and it remains a significant risk factor for morbidity and mortality, this is a less frequent cause for hospital admission compared with SLE flare or infection [15] . Additionally, given the retrospective nature of the study, where charts were identified by the discharge diagnosis of SLE, there is a potential for underreporting hospitalizations of SLE patients for reasons other than for SLE disease flare, which may account for the lower hospitalization frequencies seen. However, trained medical records personnel code known comorbidities after discharge so that lack of SLE ascertainment should be low.
The average length of hospitalization in this study (8.5 days) is slightly higher than the national average for all causes of hospitalization (7.6 days), suggesting that hospitalized SLE patients have higher in-hospital morbidity compared with the general hospitalized population [16] . This length of stay in SLE patients was comparable to other reports, ranging from 6 to 12 days [5, 17, 18] . A previous study on factors affecting length of stay in a rheumatic disease unit showed a positive association with increased disease severity, co-morbid diagnoses and complications such as adverse drug reactions [13] .
In our study, 14.3% of the SLE hospitalizations had ICU stays, translating into a significant increase in the mean hospitalization stay to 18.6 days in this subgroup. Admissions to the ICU were higher in our study compared with the reviewed literature, which quoted 44.9% of SLE hospital admissions requiring ICU admission [7, 18] . This may reflect a lower threshold for ICU admission (which is unlikely in a referral centre), a higher proportion of more severely ill SLE patients being admitted or that more patients are treated as outpatients where possible, so when they are admitted, they are the sickest SLE patients.
There were no predictive factors for those requiring ICU care vs those who did not.
As noted in the literature [19, 20] , mortality was significantly higher among ICU patients. Of the SLE patients admitted to the ICU at our centre, 27% died, compared with the literature where ICU deaths in SLE patients ranged from 29% to 79% [19, 20] . Previous studies have indicated that while overall ICU mortality is quite high, it is even higher in SLE patients [20] . Overall mortality for SLE inpatients was 5.6%, more common amongst our population compared with other studies where mortality ranged from 3.1% to 4.8% [7, 8, 17] , and likely related to the high number of ICU admissions.
In this contemporary cohort, disease flare and infection continue to be significant causes of morbidity. Disease flares are more common early in the course of disease and this suggests a need for increased frequency of outpatient visits during this time period and initial management targeting rapid remission. Increased patient and health care provider education regarding the risks of infection in SLE may encourage patients to seek attention earlier and allow for lower thresholds for suspicion of infection and initiation of appropriate antibiotics. Ideally risk factors for ICU admissions in SLE can be found and modified to prevent the high mortality and costs associated with ICU stays. The costs of SLE due to hospitalizations are still high.
Conclusion
In conclusion, the annual rate of hospitalization cannot be fully determined from this study, but the reasons for hospitalization and length of stay are similar to other North American studies except that more ICU admissions occurred in this population and the overall length of stay was higher than the mean for hospitalized patients.
Rheumatology key messages
. Flare and infection were the main reasons for hospitalizations. . ICU admissions in SLE patients were more frequent than expected. . SLE admissions had longer hospital stays and increased mortality compared with other admissions.
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